Waymo vs. Uber: The Autonomy Scale War Gets a Regulatory Reckoning
Synthetic biology’s AI protein-design tools are solving hard problems—but the real bottleneck is what happens after the code leaves the lab.
Coinbase’s CLARITY Moment—Why the Market Yawned at Legislative Friction
Neuralink’s Membrane-Sparing Surgery Resets the BCI Invasiveness Debate